CONGRESS TOPICS

DEVELOPING A NANOPARTICLE

Design

Modelling

Characterization

FROM THE ADMINISTRATION TO

THE TARGET SITE

Administration routes

Biological barriers

Immunological response

CLINICAL TRANSLATION OF NANODRUGS

Laboratory optimization

Pre-clinical safety evaluation

phase I/II/III clinical studies

Clinical successes

Industry reports